The traditional cancer drug development pathway is increasingly being superseded by trials that address multiple clinical questions. These are collectively termed Complex Innovative Design (CID) trials. CID trials not only assess the safety and toxicity of novel anticancer medicines but also their efficacy in biomarker-selected patients, specific cancer cohorts or in combination with other agents. They can be adapted to include new cohorts and test additional agents within a single protocol. Whilst CID trials can speed up the traditional route to drug licencing, they can be challenging to design, conduct and interpret.
Effective delivery of Complex Innovat... - Lung Conditions C...
Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement.
Written by
2greys
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Ground-breaking trial pilots new tests to detect lung cancer earlier. I posted about being invited for this a couple of weeks ago.
The first participants have taken part in a new research trial that aims to save lives by detecting...
Can Alzheimer’s Dementia Drugs Help With IPF ... Drug repurposing in idiopathic pulmonary fibrosis classes
Furthermore, our analysis concluded to drugs (Table 2) that provide strong connection with IPF...
Drug trials
Whilst many of us have taken part in drug trials, it seems not all outcomes are published....
Bit of a fun statement
I've seen it before. I suppose you could oimprove on that. Let's have the start of it first.
As...
Researchers show that certain antibiotics can prevent the entry of SARS-CoV-2 into cells.
The Drug Design and Molecular Topology Unit group of the University of Valencia has shown that...
New drug trials in Bradford
New saliva test could identify cancer cells in minutes
Micro Bubbles
Is there any COPD research being carried out anywhere?
